Contact this trialFirst, we need to learn more about you.
Anti-metabolites
CC-486 + Venetoclax for Acute Myeloid Leukemia
Recruiting3 awardsPhase 1
Aurora, Colorado
This trial is testing a new combination of drugs for relapsed or refractory AML patients. The first part of the trial will determine the maximum tolerated dose of the new drugs. The second part will expand the trial to more patients using the maximum tolerated dose.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.